Autres langues GSK plc

Actions

GSK

GB00BN7SWP63

Produits pharmaceutiques

Temps réel estimé 16:58:57 15/09/2026 Varia. 5j. Varia. 1 janv.
1 854,25 GBX -0,01% Graphique intraday de GSK plc +3,31% +1,73%

Autres langues

16:47 Global markets live: Amazon, BofA, ExxonMobil, OpenAI, SpaceX…
14:58 GSK Upgraded to Buy as Berenberg Notes Pipeline Momentum; Price Target Raised
14:02 Empowering Communities: ViiV Healthcare Awards $33 Million in Grants to Advance HIV Response in the U.S.
12:56 GSK to Acquire Experimental Blood Cancer Therapy From Chimagen in $750 Million Deal
12:39 Europese beurzen lager rond lunchtijd
10:54 Berenberg likes GSK; Deutsche Bank lifts Astra
10:35 GSK agrees up to USD750 million deal for blood cancer-targeting drug
09:35 GSK Agrees to Buy Potential Blood Cancer Treatment for Up to $750 Million
09:14 GSK kauft für bis zu 750 Mio Dollar Rechte an Antikörper von Chimagen
08:59 GSK in T-cell deal; Kier puts brakes on Property arm
08:47 GSK to Buy Antibody Treatment From Chimagen for Up to $750 Million
08:24 GSK to Acquire Chimagen Biosciences' T-Cell Engager Program for Up to $750 Million
08:17 GSK : to acquire potential best-in-class T cell-engager (TCE) for multiple myeloma from Chimagen Biosciences
08:12 GSK strikes up to $750 million deal for cancer-targeting drug
07:14 UK Stocks-Factors to watch on September 15
14/09 Acciones europeas caen por llamados a desacelerar la IA y preocupaciones sobre la inflación
14/09 European shares slip on AI slowdown calls and inflation concerns
14/09 Defensive stocks lift FTSE 100 at start of pivotal week for central banks
14/09 Schwächer - KI-Sorgen belasten Technologie-Werte
14/09 FTSE 100 outperforms as AI worry hits Wall Street
14/09 UK Shares Rise Ahead of BoE Rate Decision; GSK Gains on Lung Cancer Data
14/09 European Stocks Close Mixed in Monday Trading; ECB Rates Could Rise as Energy Costs Fuel Inflation
14/09 European Equities Traded in the US as American Depositary Receipts Drop in Monday Trading
14/09 GSK Plc Presents Positive Registrational Data To Potentially Expand Jideytro (Zidesamtinib) To First-Line ROS1-Positive Non-Small Cell Lung Cancer
14/09 GSK announces positive data from two clinical trials
Aucun résultat pour cette recherche
-40% : Les Meilleurs Outils Réservés aux Abonnés pour Identifier les Meilleurs Investissements de Demain !
j
:
:
PROFITEZ-EN MAINTENANT